173 related articles for article (PubMed ID: 37422846)
1. Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma.
Amin DR; Philips R; Bertoni DG; Mastrolonardo EV; Campbell DJ; Agarwal AM; Tekumalla S; Urdang ZD; Luginbuhl AJ; Cognetti DM; Curry JM
JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):980-986. PubMed ID: 37422846
[TBL] [Abstract][Full Text] [Related]
2. Survival and Gastrostomy Prevalence in Patients With Oropharyngeal Cancer Treated With Transoral Robotic Surgery vs Chemoradiotherapy.
Sharma A; Patel S; Baik FM; Mathison G; Pierce BH; Khariwala SS; Yueh B; Schwartz SM; Méndez E
JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):691-7. PubMed ID: 27347780
[TBL] [Abstract][Full Text] [Related]
3. Survival and Swallowing Function after Primary Radiotherapy versus Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
Hughes RT; Levine BJ; May N; Shenker RF; Yang JH; Lanier CM; Frizzell BA; Greven KM; Waltonen JD
ORL J Otorhinolaryngol Relat Spec; 2023; 85(5):284-293. PubMed ID: 37647863
[TBL] [Abstract][Full Text] [Related]
4. Utilization of Transoral Robotic Surgery (TORS) in patients with Oropharyngeal Squamous Cell Carcinoma and its impact on survival and use of chemotherapy.
Baliga S; Kabarriti R; Jiang J; Mehta V; Guha C; Kalnicki S; Smith RV; Garg MK
Oral Oncol; 2018 Nov; 86():75-80. PubMed ID: 30409323
[TBL] [Abstract][Full Text] [Related]
5. Outcomes following TORS for HPV-positive oropharyngeal carcinoma: PEGs, tracheostomies, and beyond.
Van Abel KM; Quick MH; Graner DE; Lohse CM; Price DL; Price KAR; Ma DJ; Moore EJ
Am J Otolaryngol; 2019; 40(5):729-734. PubMed ID: 31303455
[TBL] [Abstract][Full Text] [Related]
6. Association of Transoral Robotic Surgery With Short-term and Long-term Outcomes and Costs of Care in Oropharyngeal Cancer Surgery.
Motz K; Chang HY; Quon H; Richmon J; Eisele DW; Gourin CG
JAMA Otolaryngol Head Neck Surg; 2017 Jun; 143(6):580-588. PubMed ID: 28358930
[TBL] [Abstract][Full Text] [Related]
7. A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx.
Albergotti WG; Jordan J; Anthony K; Abberbock S; Wasserman-Wincko T; Kim S; Ferris RL; Duvvuri U
Cancer; 2017 Aug; 123(16):3132-3140. PubMed ID: 28467606
[TBL] [Abstract][Full Text] [Related]
8. Quality of Life After Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharynx Cancer.
Silver JA; Bouganim N; Richardson K; Henry M; Mascarella MA; Ramirez-GarciaLuna J; Golabi N; Mlynarek AM; Zeitouni A; Hier MP; Caglar D; Esfahani K; Sadeghi N
JAMA Otolaryngol Head Neck Surg; 2024 Jan; 150(1):65-74. PubMed ID: 38060238
[TBL] [Abstract][Full Text] [Related]
9. Treatment outcomes of transoral robotic and non-robotic surgeries to treat oropharyngeal, hypopharyngeal, and supraglottic squamous cell carcinoma: A multi-center retrospective observational study in Japan.
Sano D; Shimizu A; Tateya I; Fujiwara K; Mori T; Miyamoto S; Nishikawa D; Terada T; Yasumatsu R; Ueda T; Matsumoto F; Kishimoto Y; Maruo T; Fujimoto Y; Tsukahara K; Yoshimoto S; Nibu KI; Oridate N
Auris Nasus Larynx; 2021 Jun; 48(3):502-510. PubMed ID: 33632582
[TBL] [Abstract][Full Text] [Related]
10. Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial.
Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
J Clin Oncol; 2022 Mar; 40(8):866-875. PubMed ID: 34995124
[TBL] [Abstract][Full Text] [Related]
11. Long-term Functional and Quality-of-Life Outcomes After Transoral Robotic Surgery in Patients With Oropharyngeal Cancer.
Achim V; Bolognone RK; Palmer AD; Graville DJ; Light TJ; Li R; Gross N; Andersen PE; Clayburgh D
JAMA Otolaryngol Head Neck Surg; 2018 Jan; 144(1):18-27. PubMed ID: 29075740
[TBL] [Abstract][Full Text] [Related]
12. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation.
Ling DC; Chapman BV; Kim J; Choby GW; Kabolizadeh P; Clump DA; Ferris RL; Kim S; Beriwal S; Heron DE; Duvvuri U
Oral Oncol; 2016 Oct; 61():41-6. PubMed ID: 27688103
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Eapen L; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
Lancet Oncol; 2019 Oct; 20(10):1349-1359. PubMed ID: 31416685
[TBL] [Abstract][Full Text] [Related]
14. Optimized decision support for selection of transoral robotic surgery or (chemo)radiation therapy based on posttreatment swallowing toxicity.
Hemmati M; Barbon C; Mohamed ASR; van Dijk LV; Moreno AC; Gross ND; Goepfert RP; Lai SY; Hutcheson KA; Schaefer AJ; Fuller CD;
Cancer Med; 2023 Feb; 12(4):5088-5098. PubMed ID: 36229990
[TBL] [Abstract][Full Text] [Related]
15. National Trends in 30-Day Readmission Following Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma.
Nyirjesy SC; McCrary HC; Zhao S; Judd RT; Farlow JL; Seim NB; Ozer E; Agrawal A; Old MO; Rocco JW; Kang SY; Haring CT
JAMA Otolaryngol Head Neck Surg; 2024 Feb; 150(2):133-141. PubMed ID: 38153724
[TBL] [Abstract][Full Text] [Related]
16. Treatment of oropharyngeal squamous cell carcinoma: Is swallowing quality better after TORS or RT?
Campo F; Iocca O; De Virgilio A; Mazzola F; Mercante G; Pichi B; Holsinger FC; Di Maio P; Ramella S; Pellini R
Radiother Oncol; 2023 Jun; 183():109547. PubMed ID: 36813176
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for gastrostomy tube dependence in transoral robotic surgery patients.
Philips R; Topf MC; Vimawala S; Luginbuhl A; Curry JM; Cognetti DM
Am J Otolaryngol; 2022; 43(1):103175. PubMed ID: 34418824
[TBL] [Abstract][Full Text] [Related]
18. Quality of life outcomes of transoral robotic surgery with or without adjuvant therapy for oropharyngeal cancer.
Sethia R; Yumusakhuylu AC; Ozbay I; Diavolitsis V; Brown NV; Zhao S; Wei L; Old M; Agrawal A; Teknos TN; Ozer E
Laryngoscope; 2018 Feb; 128(2):403-411. PubMed ID: 28771728
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of transoral laser microsurgery and transoral robotic surgery in oropharyngeal squamous cell carcinoma.
Sievert M; Goncalves M; Zbidat A; Traxdorf M; Mueller SK; Iro H; Gostian AO
Auris Nasus Larynx; 2021 Apr; 48(2):295-301. PubMed ID: 32883577
[TBL] [Abstract][Full Text] [Related]
20. Comparison of margins and survival between transoral robotic surgery (TORS) and non-robotic endoscopic surgery for oropharyngeal cancer.
Groysman M; Gleadhill C; Baker A; Wang SJ; Bearelly S
Am J Otolaryngol; 2023; 44(6):103982. PubMed ID: 37531886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
